Martin G. Larson

6 ta ish

Boston University

1. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

   Renate B. Schnabel, Xiaoyan Yin, Philimon Gona +12

   Maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.295656

2. Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart Study

   Meredith C. Foster, Shih‐Jen Hwang, Martin G. Larson +5

   Maqola20083 iqtibos

   ABIABI:AkademIndex/2026.other.535993

3. Metabolite profiles and the risk of developing diabetes

   Thomas J. Wang, Martin G. Larson, Ramachandran S. Vasan +15

   Maqola20113 iqtibos

   ABIABI:AkademIndex/2026.other.706653

4. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

   Eugene P. Rhee, Susan Cheng, Martin G. Larson +13

   MaqolaOAOchiq kirish20112 iqtibos

   ABIABI:AkademIndex/2026.other.032856

5. Obesity and the Risk of Heart Failure

   Satish Kenchaiah, Jane C. Evans, Daniel Levy +5

   Maqola20022 iqtibos

   ABIABI:AkademIndex/2026.other.295691

6. Impact of Obesity on Plasma Natriuretic Peptide Levels

   Thomas J. Wang, Martin G. Larson, Daniel Levy +4

   Maqola20042 iqtibos

   ABIABI:AkademIndex/2026.other.295714